Cue Biopharma Reports Quarterly Results for Quarter Ended June 30, 2026

What Happened
Cue Biopharma, Inc. (CUE) announced financial results and business highlights for the quarter ended June 30, 2026. The company issued a press release on August 14, 2026 reporting those quarterly results; that press release is furnished as Exhibit 99.1 to a Current Report on Form 8-K filed the same day. The Form 8-K was signed by President and CEO Shao‑Lee Lin.

Key Details

• Filed Form 8-K on August 14, 2026 to report results of operations and financial condition (Item 2.02).
• Press release covering the quarter ended June 30, 2026 is furnished as Exhibit 99.1 and is incorporated by reference.
• The filing also includes the exhibit listing under Item 9.01(d) (Exhibit 99.1 and Inline XBRL cover page).
• Form 8-K was signed by Shao‑Lee Lin, President and Chief Executive Officer, on August 14, 2026.

Why It Matters
This filing signals that Cue Biopharma has publicly released its latest quarterly financial results and business updates — material information for investors. The 8-K references a press release with the specific figures and operational highlights; shareholders and prospective investors should read Exhibit 99.1 to see revenue, earnings (or losses), cash position, and any program or pipeline updates disclosed by the company.